SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001113423-17-000010
Filing Date
2017-03-16
Accepted
2017-03-15 19:15:20
Documents
12
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 20-F aezs20-f2016.htm 20-F 3730540
2 EXHIBIT 4.9 exhibit49-20xfx2016.htm EX-4.9 42328
3 EXHIBIT 8.1 exhibit81-20xfx2016.htm EX-8.1 20047
4 EXHIBIT 12.1 exhibit121-20xfx2016.htm EX-12.1 12241
5 EXHIBIT 12.2 exhibit122-20xfx2016.htm EX-12.2 12504
6 EXHIBIT 13.1 exhibit131-20xfx2016.htm EX-13.1 8199
7 EXHIBIT 13.2 exhibit132-20xfx2016.htm EX-13.2 8257
8 EXHIBIT 15.1 exhibit151-20xfx2016.htm EX-15.1 5740
9 pipelinenotactivedeveloa01.jpg GRAPHIC 53253
10 rdpipelinejanuary2017a01.jpg GRAPHIC 56679
11 signatpwcfs.jpg GRAPHIC 7895
12 tumora02.jpg GRAPHIC 48993
  Complete submission text file 0001113423-17-000010.txt   4054973
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-30752 | Film No.: 17692571
SIC: 2834 Pharmaceutical Preparations